ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program

Maximus to Leverage its Award-Winning Approach to Customer Experience to Expand CDC-INFO’s Capabilities

Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it had been awarded a contract for one base year plus four option years from the Centers for Disease Control and Prevention (CDC). Under the contract, which has an awarded value of $100 million over five years, Maximus will leverage its technology capabilities and operational improvement skills for the CDC-INFO program, which provides critical health information to millions of Americans.

“At Maximus, we are motivated to help federal agencies overcome their biggest challenges, and there has been no greater challenge in our lifetime than the COVID-19 pandemic,” said Teresa Weipert, General Manager, Federal Services, Maximus. “We are proud of what we’ve accomplished with CDC and look forward to evolving the CDC-INFO program through the use of emerging technologies so the agency is prepared for whatever may come next.”

Maximus has supported the CDC-INFO program throughout the COVID-19 pandemic. This included the implementation of the National COVID-19 Vaccination Assistance Hotline (CDC-VAX) and its growth as the need for expertise surged. The success of the CDC-VAX program has led to multiple award wins for the agency and Maximus over the past year, including being honored in the 2022 Service to the Citizen Awards.

Under the new contract period of performance, Maximus will make several digitally-enabled enhancements to improve communications of accurate, timely, and consistent health information to the public, providers, and federal partners. Using real-time data and call analytics to better identify trends, as well as track and improve customer satisfaction, Maximus is applying its proven approach to enhancing the Customer Experience on the CDC-INFO program.

“Agencies build trust with their constituents through excellent customer service and Maximus is uniquely positioned to ensure that interactions with CDC-INFO end with proper information being conveyed quickly and efficiently,” said Lisa Slaughter, Senior Vice President, Maximus. “This CDC-INFO program will benefit from our experience serving millions of Americans through the CDC-VAX program, as we will focus on improving the user experience for those seeking information and effectively implement the technologies needed to make that happen.”

To learn more about how Maximus has supported CDC during COVID-19, please visit this case study on the implementation and ongoing support of the CDC-VAX program: maximus.com/case-study/cdc-vax-helping-millions-get-vaccinated.

About Maximus

As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.